These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 4119954)
41. The mechanism of action of clofibrate and tetranicotinoylfructose (Bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia. Kissebah AH; Adams PW; Harrigan P; Wynn V Eur J Clin Invest; 1974 Jun; 4(3):163-74. PubMed ID: 4838694 [No Abstract] [Full Text] [Related]
42. Serum cholesterol levels in US males. Their correlation with various kinetic parameters of cholesterol metabolism. Ho KJ; Biss K; Taylor CB Arch Pathol; 1974 May; 97(5):306-15. PubMed ID: 4818733 [No Abstract] [Full Text] [Related]
43. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] lipid metabolism. II. Effects on the incorporation of various isotopic precursors in rat liver]. Priego JG; Maroto ML; Piña M; Catalán RE Arch Farmacol Toxicol; 1978 Apr; 4(1):28-30. PubMed ID: 697397 [No Abstract] [Full Text] [Related]
44. [Familial hyperlipoproteinemia type III]. Patsch JR; Patsch W; Sailer S; Braunsteiner H Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039 [No Abstract] [Full Text] [Related]
45. [Systematic study of a median tolerance to a high-fat test diet in hyperlipemia or hyperglyceridemia]. de Gennes JL; Truffert J; Salmon D; de Tregomain B; Bouchon JP Ann Med Interne (Paris); 1969 Dec; 120(12):787-802. PubMed ID: 5377660 [No Abstract] [Full Text] [Related]
46. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia. Grundy SM; Mok HY J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472 [TBL] [Abstract][Full Text] [Related]
47. Atherosclerosis as a pediatric problem. Wells CR Del Med J; 1974 Sep; 46(9):457-63. PubMed ID: 4369794 [No Abstract] [Full Text] [Related]
48. Ileal bypass in treatment of hyperlipidemia: rationale and present status. Gomes MM; Bernatz PE; Kottke BA; Juergens JL; Titus JL Mayo Clin Proc; 1970 Mar; 45(3):229-41. PubMed ID: 4985180 [No Abstract] [Full Text] [Related]
50. Classifications of the hyperlipidemias. Havel RJ Annu Rev Med; 1977; 28():195-209. PubMed ID: 193431 [No Abstract] [Full Text] [Related]
51. An update on the hyperlipidemias and atherosclerosis. Powell RC Indiana Med; 1984 Jun; 77(6):441-5. PubMed ID: 6736617 [No Abstract] [Full Text] [Related]
52. Effect of nicotinic acid on muscle lipid concentration in man. Fröberg SO; Castenfors H Acta Med Scand; 1974; 196(1-2):65-7. PubMed ID: 4418517 [No Abstract] [Full Text] [Related]
53. Lipid metabolism and ischaemic heart disease in the elderly. Horsey J; Livesley B Age Ageing; 1976 May; 5(2):75-83. PubMed ID: 1274801 [No Abstract] [Full Text] [Related]
54. [Regulation of cholesterol synthesis in the rat liver under the influence of serum cholesterol-decreasing drugs]. Kaiser W; Zöllner N Verh Dtsch Ges Inn Med; 1972; 78():1307-10. PubMed ID: 4665529 [No Abstract] [Full Text] [Related]
59. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. Orö L; Olsson AG; Rössner S; Carlson LA Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986 [TBL] [Abstract][Full Text] [Related]
60. Dietary cholesterol versus total body cholesterol. Nutr Rev; 1971 Sep; 29(9):199-201. PubMed ID: 4942170 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]